Reassessment of risk genotypes (GRN, TMEM106B, and ABCC9 variants) associated with hippocampal sclerosis of aging pathology.

J Neuropathol Exp Neurol

From the Departments of Pathology (PTN) and Biostatistics (DWF), Sanders-Brown Center on Aging (PTN, W-XW, BRW, DWF), and Division of Biomedical Informatics, College of Public Health (SRE), University of Kentucky, Lexington, Kentucky; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania (ABP, OV, L-SW); National Alzheimer's Coordinating Center (SEM) and Department of Epidemiology (WAK), University of Washington, Seattle, Washington; and Department of Biostatistics and Epidemiology, Perelman School of Medicine (ACN).

Published: January 2015

Hippocampal sclerosis of aging (HS-Aging) is a common high-morbidity neurodegenerative condition in elderly persons. To understand the risk factors for HS-Aging, we analyzed data from the Alzheimer's Disease Genetics Consortium and correlated the data with clinical and pathologic information from the National Alzheimer's Coordinating Center database. Overall, 268 research volunteers with HS-Aging and 2,957 controls were included; detailed neuropathologic data were available for all. The study focused on single-nucleotide polymorphisms previously associated with HS-Aging risk: rs5848 (GRN), rs1990622 (TMEM106B), and rs704180 (ABCC9). Analyses of a subsample that was not previously evaluated (51 HS-Aging cases and 561 controls) replicated the associations of previously identified HS-Aging risk alleles. To test for evidence of gene-gene interactions and genotype-phenotype relationships, pooled data were analyzed. The risk for HS-Aging diagnosis associated with these genetic polymorphisms was not secondary to an association with either Alzheimer disease or dementia with Lewy body neuropathologic changes. The presence of multiple risk genotypes was associated with a trend for additive risk for HS-Aging pathology. We conclude that multiple genes play important roles in HS-Aging, which is a distinctive neurodegenerative disease of aging.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4270894PMC
http://dx.doi.org/10.1097/NEN.0000000000000151DOI Listing

Publication Analysis

Top Keywords

hs-aging
9
risk genotypes
8
hippocampal sclerosis
8
sclerosis aging
8
hs-aging risk
8
risk hs-aging
8
risk
6
reassessment risk
4
genotypes grn
4
grn tmem106b
4

Similar Publications

Article Synopsis
  • Neurodegenerative diseases not only result in memory loss and cognitive decline but also lead to behavioral and psychological symptoms of dementia (BPSD) that negatively impact quality of life and complicate treatment.
  • A study analyzing 368 autopsied participants revealed various BPSD, such as agitation and anxiety, correlated with different types of brain pathology, including Alzheimer's disease and other neurodegenerative conditions.
  • Individuals with severe Alzheimer's-related changes exhibited more BPSD symptoms, particularly in cases with multiple pathologies, while disinhibition and language issues were frequently observed but not linked to any specific type of pathology.
View Article and Find Full Text PDF

Hippocampal sclerosis (HS) is associated with advanced age as well as transactive response DNA-binding protein with 43 kDa (TDP-43) deposits. Both hippocampal sclerosis and TDP-43 proteinopathy have also been described in chronic traumatic encephalopathy (CTE), a neurodegenerative disease linked to exposure to repetitive head impacts (RHI). However, the prevalence of HS in CTE, the pattern of TDP-43 pathology, and associations of HS and TDP-43 with RHI are unknown.

View Article and Find Full Text PDF
Article Synopsis
  • TDP-43 proteinopathy affects at least 25% of individuals over 85 years old and is linked to significant cognitive decline, with risk factors including genetic variants, Alzheimer's disease, and thyroid hormone issues.
  • A study of 136 autopsy subjects from the University of Kentucky found that approximately 46.4% had TDP-43 inclusions, aligning with previous research, and identified correlations with hippocampal sclerosis of aging (HS-Aging) genotypes.
  • Additionally, the research indicated that lower levels of thyroid hormones (T3 and T4) may be connected to TDP-43 pathology, particularly in individuals with specific genetic risk factors, suggesting thyroid hormone signaling may influence age-related TDP-43 protein
View Article and Find Full Text PDF

Objective: To characterize the pattern of neuron loss in hippocampal sclerosis of aging (HS-Aging) and age-related diseases and to evaluate its contribution to cognitive impairment in the elderly.

Methods: Participants (n = 1,361) came from longitudinal observational studies of aging at the Knight Alzheimer Disease Research Center, Washington University (St. Louis, MO).

View Article and Find Full Text PDF

Non-Alzheimer's contributions to dementia and cognitive resilience in The 90+ Study.

Acta Neuropathol

September 2018

Department of Pathology and Laboratory Medicine, Center for Neurodegenerative Disease Research, Institute on Aging, University of Pennsylvania, Philadelphia, PA, USA.

The diagnosis of Alzheimer's disease (AD) in the oldest-old is complicated by the increasing prevalence of age-related neurofibrillary tangles, plaques and non-AD pathologies such as cerebrovascular disease (CVD), hippocampal sclerosis (HS), aging-related tau astrogliopathy (ARTAG), as well as TDP-43 and Lewy pathology. The contribution of these non-AD pathologies to dementia and cognitive resilience is unclear. We assessed the level of AD neuropathologic change (ADNPC) and non-AD pathology in 185 participants enrolled in The 90+ Study with available cognitive assessments and brain tissue.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!